Health
New method for producing FTVI enzyme can help improve cord blood transplants – News-Medical.Net
A new way of producing an enzyme called fucosyltransferase VI (FTVI) in the lab could help enhance the therapeutic potential of cord blood transplants.
Reviewed by Emily Henderson, B.Sc.Oct 22 2020
Stem cell trafficking to the bone marrow is improved by enzyme manufactured in silkworms and yeast.
A new way of producing an enzyme called fucosyltransferase VI (FTVI) in the lab could help enhance the therapeutic potential of cord blood transplants.
Cord blood is currently used to treat more than 80 life-threatening conditions, ranging from cancer and immune deficiency to metabolic and genetic disorders.
The therapy is predicated on the idea that stem…
-
Business24 hours agoWhy Amotiv, Breville, Life360, and Woodside shares are tumbling today
-
Business20 hours agoOwn the world with these 3 global ASX ETFs
-
Noosa News24 hours agoQueensland police to be given powers to issue on-the-spot orders to domestic violence perpetrators
-
Business20 hours agoASX 200 plunges as US tariffs fall-out continues